Equities research analysts expect Rewalk Robotics Ltd (NASDAQ:RWLK) to post ($0.31) earnings per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Rewalk Robotics’ earnings, with the highest EPS estimate coming in at ($0.22) and the lowest estimate coming in at ($0.39). Rewalk Robotics reported earnings of ($0.47) per share in the same quarter last year, which suggests a positive year-over-year growth rate of 34%. The firm is scheduled to report its next quarterly earnings report on Friday, February 16th.
According to Zacks, analysts expect that Rewalk Robotics will report full year earnings of ($1.11) per share for the current financial year, with EPS estimates ranging from ($1.22) to ($1.00). For the next financial year, analysts anticipate that the firm will report earnings of ($1.26) per share, with EPS estimates ranging from ($1.27) to ($1.24). Zacks’ EPS averages are an average based on a survey of research analysts that cover Rewalk Robotics.
Rewalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings results on Thursday, November 2nd. The medical device company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.32) by $0.10. The company had revenue of $1.70 million during the quarter, compared to analysts’ expectations of $1.63 million. Rewalk Robotics had a negative return on equity of 568.25% and a negative net margin of 346.14%. Rewalk Robotics’s quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the business earned ($0.62) earnings per share.
Shares of Rewalk Robotics (RWLK) traded up $0.05 during mid-day trading on Friday, reaching $1.10. The company had a trading volume of 421,771 shares, compared to its average volume of 328,747. The company has a debt-to-equity ratio of 7.46, a quick ratio of 1.65 and a current ratio of 2.02. The stock has a market capitalization of $30.37, a PE ratio of -0.69 and a beta of 0.79. Rewalk Robotics has a 52 week low of $1.05 and a 52 week high of $3.60.
Several institutional investors have recently bought and sold shares of RWLK. Renaissance Technologies LLC increased its position in shares of Rewalk Robotics by 61.7% in the first quarter. Renaissance Technologies LLC now owns 78,600 shares of the medical device company’s stock valued at $165,000 after buying an additional 30,000 shares in the last quarter. Essex Investment Management Co. LLC increased its position in shares of Rewalk Robotics by 328.7% in the third quarter. Essex Investment Management Co. LLC now owns 156,981 shares of the medical device company’s stock valued at $228,000 after buying an additional 120,362 shares in the last quarter. Finally, Advisor Group Inc. increased its position in shares of Rewalk Robotics by 1,495.6% in the third quarter. Advisor Group Inc. now owns 181,900 shares of the medical device company’s stock valued at $264,000 after buying an additional 170,500 shares in the last quarter. Institutional investors and hedge funds own 3.23% of the company’s stock.
About Rewalk Robotics
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.